insights_auto
Why is ORX down 3,08%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
0,85 SEK
arrow_downward
-3,08%(-0,027) 1D
16-ноя., 17:29:42 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
0,89 SEK
High
0,89 SEK
Low
0,82 SEK
Mkt. cap
297,56 млн
Avg. vol.
777,72 миң
Volume
415,89 миң
P/E ratio
0,06
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
0,89 SEK
High
0,89 SEK
Low
0,82 SEK
Mkt. cap
297,56 млн
Avg. vol.
777,72 миң
Volume
415,89 миң
P/E ratio
0,06
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
ChartMill
·
52 мүнөт мурун
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
Investing.com
·
1 саат мурун
Why is SPDR S&P 500 ETF sliding today?
The Motley Fool
·
21 мүнөт мурун
Here's How the S&P 500 Has Moved the Day After Each of Nvidia's Last 12 Reports
cwibc.co.id
·
5 саат мурун
Nasdaq and S&P 500 Fall Ahead of Nvidia Earnings
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com